Expert articles on effective weight loss, Mounjaro, and peptides
124 articles
The largest knowledge base on GLP-1 and peptides
The only D2C resource in Europe combining 24+ guides on Mounjaro, 19+ on Ozempic and 53+ peptide protocols in one place. Clinically oriented materials, updated weekly.
A practical guide: which tests to take, who shouldn't use GLP-1, how dose titration works, and what to expect in the first weeks. Everything you need to know before starting.
Scientific evidence on the relationship between weight and reproductive health. How obesity affects hormones, ovulation, sperm, and pregnancy outcomes — and what to do about it.
Obesity isn't a cosmetic problem. Without treatment, it leads to diabetes, heart disease, sleep apnea, fatty liver disease, and cancer. But most complications are reversible with weight loss.
Two products with the same name — a herbal supplement and Havinson's tetrapeptide. We analyze how they work and what suits whom.
Comparison of three approaches to reducing dangerous visceral fat: caloric deficit, GLP-1 agonists, and Tesamorelin. Clinical trial data.
We compare nasal Selank 0.15% drops and injectable AC-Selank-NH2: bioavailability, dosing precision, and when each works better.
Ready to lose weight with Mounjaro?
Free specialist consultation — we'll select the right dose and program for you
Comparing BPC-157 injections and capsules: bioavailability 45-51% vs 14-19%, when each form works best, and how to choose the right format for your goals.
Why does weight stall even with caloric deficit? We examine two metabolic brakes — NNMT and AMPK — and peptides that release them.
Visceral fat is an invisible enemy surrounding your organs, increasing mortality risk by 178%. Discover why diets fail and how the only FDA-approved peptide Tesamorelin targets it specifically.
Three approaches to cognitive enhancement: BDNF pathway of peptides, GABA agonism with addiction risk, and cholinergic modulation without evidence base. Breaking down the science.
How synthetic peptide P21 reproduces Cerebrolysin's neurotrophic effects without intravenous infusions — mechanism of action, research, subcutaneous protocol.
